1.
Through This project the vaccine quantity will be
increased to one million doses per annum.
2.
To replace Complement Fixation test with two way ELISA
system. Adopting of new technology will help to find out
the type of FMD virus involved within hours without false
results as the ELISA system is highly specific and
broad-based. Further this system will enable the Centre to
monitor serum for antibody response against different FMD
virus.
3.
Currently, only type “O” vaccine is being produced in
Pakistan.
At least bivalent vaccine having the most prevalent types
shall be produced and supplied in the field to afford
better protection. |